Intensity-Modulated Proton Therapy (IMPT) Treatment of Angiosarcoma of the Face and Scalp by Ashley Hunzeker, MS, CMD, Daniel W. Mundy, PhD, Jiasen Ma, PhD, Trey C. Mullikin, MD, Robert L. Foote, MD

Get full text

Outcomes of Proton Beam Therapy Compared With Intensity-Modulated Radiation Therapy for Uterine Cancer by Justin D. Anderson, MD, Molly M. Voss, Brady S. Laughlin, MD, Allison E. Garda, MD, Khaled Aziz, Trey C. Mullikin, MD, Michael G. Haddock, MD, Ivy A. Petersen, MD, Todd A. DeWees, PhD, Sujay A. Vora, MD

Get full text

Outcomes in Patients with Intact and Resected Brain Metastasis Treated with 5-Fraction Stereotactic Radiosurgery by David J. Carpenter, MD, Andrew T. Fairchild, MD, Justus D. Adamson, PhD, Peter E. Fecci, MD, PhD, John H. Sampson, MD, PhD, James E. Herndon, II, PhD, Jordan A. Torok, MD, Trey C. Mullikin, MD, Grace J. Kim, MD, PhD, Zachary J. Reitman, MD, PhD, John P. Kirkpatrick, MD, PhD, Scott R. Floyd, MD, PhD

Get full text

Determinants of Symptomatic Intracranial Progression After an Initial Stereotactic Radiosurgery Course by Jim X. Leng, MD, David J. Carpenter, MD, MS, Christina Huang, MD, MS, Jamiluddin Qazi, MD, Muzamil Arshad, MD, PhD, Trey C. Mullikin, MD, Zachary J. Reitman, MD, PhD, John P. Kirkpatrick, MD, PhD, Scott R. Floyd, MD, PhD, Peter E. Fecci, MD, PhD, Steven J. Chmura, MD, PhD, Julian C. Hong, MD, MS, Joseph K. Salama, MD

Get full text

Single and Multifraction Spine Stereotactic Body Radiation Therapy and the Risk of Radiation Induced Myelopathy by J. John Lucido, PhD, Trey C. Mullikin, MD, Feven Abraha, BS, W. Scott Harmsen, MS, Birjoo D. Vaishnav, PhD, Debra H. Brinkmann, PhD, Roman O. Kowalchuk, MD, Joseph T. Marion, MD, Benjamin A. Johnson-Tesch, MD, Omar El Sherif, PhD, Paul D. Brown, MD, Peter S. Rose, MD, Dawn Owen, MD, PhD, Jonathan M. Morris, MD, Mark R. Waddle, MD, Brittany L. Siontis, MD, Bradley J. Stish, MD, PhD, Deanna H. Pafundi, PhD, Nadia N. Laack, MD, Kenneth R. Olivier, MD, Sean S. Park, MD, PhD, Kenneth W. Merrell, MD

Get full text